Application Information

Application Number : 2024/009977

Application Date : 27-05-2016

Application Type : EPC Fasikül

Grant Number : 2024-GE-517967

Grant Date : 31-07-2024

Registration Number : 2024 009977

Registration Date : 2024-09-23

Protection Type : Patent

European Patent Publication Number (B1) : EP3302551B1

European Patent Application Number : EP16730123.3

Applicants

Person No	Name	Address
7590940	F. HOFFMANN-LA ROCHE AG	GRENZACHERSTRASSE 124, CH-4070 BASEL İSVİÇRE

Inventors

Person No	Name	Address
7725952	Elizabeth Alice GUARDINO	1 DNA WAY SOUTH SAN FRANCISCO, CA 94080 A.B.D.
7725953	Meghna SAMANT	1 DNA WAY SOUTH SAN FRANCISCO, CA 94080 A.B.D.
7725956	Monika PATRE	1 DNA WAY SOUTH SAN FRANCISCO, CA 94080 A.B.D.
7725955	Melanie SMITT	1 DNA WAY SOUTH SAN FRANCISCO, CA 94080 A.B.D.
7725954	Alexander STRASAK	1 DNA WAY SOUTH SAN FRANCISCO, CA 94080 A.B.D.

Invention Information

Name Of Invention	Her2-pozitif önceden tedavi edilmemiş metastatik meme kanserini tedavi etme yöntemleri.
Summary Of Invention	HER2-pozitif, birinci basamak metastatik veya lokal olarak ilerlemiş meme kanseri olan hastaları tedavi etme yöntemleri sağlanmaktadır.

Attorney Information

Name	FULYA SÜMERALP SİMAJ PATENT DAN. LTD. ŞTİ.
Address	HEKİMKÖY SİTESİ 1933 SOK.NO:8 - ÜMİTKÖY/ ANKARA

Priority Information

Date of Priority	Priority Number	Country of Priority
30-05-2015	US 201562168809P	US

Classes of The Invention

Patent Application Procedures

Date	Date of Notification	Operation
29-04-2025		Yıllık Ücret Ödeme Talebi
	16-09-2024	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
31-07-2024		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
23-09-2024	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)
10	2025	29-04-2025	8090.0